Cryolife reported $4.54M in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbott ABT:US $ 2388M 524M
Atricure ATRC:US $ -13.66M 0.49M
Baxter International BAX:US $ 351M 188M
Becton, Dickinson and BDX:US $ 535M 117M
Boston Scientific BSX:US $ 423M 43M
Cardiovascular Systems CSII:US $ -9.48M 0.16M
Cryolife CRY:US $ 4.54M 3.38M
Edwards Lifesciences EW:US $ 459.5M 20.7M
Inogen INGN:US $ -2876000 10.71M
Integra Lifesciences IART:US $ 61.06M 13.6M
Johnson & Johnson JNJ:US $ 5840M 22M
Mesa Laboratories MLAB:US $ -4.59M 4.48M
Natus Medical BABY:US $ 4.18M 0.52M
Pfizer PFE:US $ 12102M 2229M
Resmed RMD:US $ 255.4M 21.13M
Stryker SYK:US $ 772M 325M
Surmodics SRDX:US $ -7.14M 2.24M
Tandem Diabetes Care TNDM:US $ -12.24M 3.1M
Teleflex TFX:US $ 135.16M 31.62M
Terumo 4543:JP Y 30427M 8922M
Trinity Biotech TRIB:US $ -10.1M 10.68M